| Robert E. Bolcome, III, Ph.D. |
 |
 |
|
Robert Bolcome was born in Gloucester, Massachusetts in 1982. He earned a B.S. in Biology from Northeastern University in 2005 and a Ph.D. in Cell and Developmental Biology from Harvard University in 2010. Dr. Bolcome’s graduate studies focused on the characterization of host cell signaling processes involved in anthrax toxin-induced cardiovascular defects. His research encompassed the areas of angiogenesis, microbial pathogenesis, cancer biology, and cell biology. Dr. Bolcome was a recipient of the Manfred Karnovsky Fellowship. Dr. Bolcome is currently an evening student at Fordham University School of Law where he is a Wilkinson Scholar and Fordham Law Review staff member. He is also a student member of the American Bar Association and is registered to practice before the U.S. Patent and Trademark Office. Publications: Juris J.J., Melnyk R.A., Bolcome R.E., III, Chan J., Collier R.J. Cross-linked Forms of the Isolated N-terminal Domain of the Lethal Factor are Potent Inhibitors of Anthrax Toxin. Infection and Immunity. 2007 Oct; 75(10): 5052-8. Bolcome R.E., III, Sullivan S.E., Zeller R., Barker A.P., Collier R.J., and Chan J. Anthrax Lethal Toxin Induced Cell Death-Independent Permeability in Zebrafish Vasculature. PNAS. 2008 Feb 19;105(7):2439-44. Gryllos I., Tran-Winkler H.J., Cheng M.F., Chung H., Bolcome R.E., III, Lu W., Lehrer R.I., Wessels M.R. Induction of Group A Streptococcus Virulence by a Human Antimicrobial Peptide. PNAS. 2008 Oct 28;105(43):16755-60. Vasil M.L., Stonehouse M.J., Vasil A.I., Wadsworth S.J., Goldfine H., Bolcome R.E., III, Chan J. A Novel Extracellular Sphingomyelinase of Pseudomonas aeruginosa Inhibits Angiogenesis by Selective Cytotoxicity to Endothelial Cells. PLoS Pathog. 2009 May; 5(5): e1000420. Bolcome R.E., III and Chan J. Constitutive MEK1 Activation Rescues Anthrax Lethal Toxin Induced Vascular Effects In Vivo. Infection and Immunity. 2010 Sept 20. [Epub ahead of print]
|
